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ABSTRACT 
 
 
Regulation and Expression of Nanog, Oct4, and Sox2 in the Bovine Blastocyst Following  
 
Somatic Cell Nuclear Transfer 
 
 
by 
 
 
Justin Scott Hall, Master of Science 
 
Utah State University, 2013  
 
 
Major Professor: Dr. Kenneth L. White 
Department: Animal, Dairy, and Veterinary Sciences  
 
  
A live birth from a somatic cell nuclear transfer (SCNT) embryo represents a 
small percentage of donor cells that survived the reprogramming gauntlet. The inability 
to reprogram histone modifications in the donor cell line could add to the reprogramming 
deficiencies associated with SCNT. The effects of two histone modifications associated 
with transcriptional activation (H3K4m3 and H4K16ac) and two histone modifications 
associated with repressing transcription (H3K9m2 and H3K27me3) were evaluated in the 
context of their association to three genes known to contribute to maintaining totipotency: 
Nanog, Oct4, and Sox2. A !ChIP assay was utilized using antibodies specific for each 
histone modification followed by real time PCR (qPCR) analysis to quantify the 
percentage of each gene associated with each particular histone modification. Gene 
expression analysis was followed by immunofluorescence and protein analysis. Results 
of these analyses suggest that gene association to certain histone modifications did not 
accurately predict gene expression in bovine blastocyst embryos. Of the three genes 
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studied, only Oct4 expression differed significantly between in vitro fertilized (IVF; 
control) and SCNT blastocysts. Protein levels detected through immunofluorescence 
correlated directly with the gene expression analysis. Nanog and Sox2 expression profiles 
of IVF and SCNT bovine blastocysts are similar, yet the histone modification profiles 
associated with all three genes differ significantly. Altered expression levels in 
developmentally important genes will likely result in abnormal activity of the associated 
cellular pathway. Aberrant histone modifications, along with abnormal Oct4 expression, 
may contribute to the low percentage of SCNT embryos that result in live offspring. 
 
(56 pages) 
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PUBLIC ABSRACT 
 
 
Regulation and Expression of the Nanog, Oct4, and Sox2 Genes in the Bovine Embryo  
 
Following Somatic Cell Nuclear Transfer 
 
Justin S. Hall Master of Science 
 
The Animal, Dairy, and Veterinary Sciences Department (ADVS) and the Center 
for Integrated Biosystems (CIB) at Utah State University are studying various molecular 
mechanisms involved in the animal cloning process. This study involves the extensive 
network of people, facilities, equipment, and funding already associated with the CIB and 
ADVS joint project. 
 Cloning involves many molecular challenges that for the most part have become 
roadblocks for the normal development of the fetus. The mechanisms necessary to 
transform an adult cell into a competent stem cell that can then transform and develop 
into a healthy organism are poorly understood. Some of these roadblocks have been 
broadly defined. In this study histone modifications are examined in terms of how they 
might influence the expression of three developmentally important genes (Nanog, Oct4, 
and Sox2). Understanding the molecular mechanisms and their role in histone 
modifications and subsequent gene expression in early development will lead to 
identifying genetic deficiencies that contribute to the poor success in animal cloning.  
 Currently animal cloning is very inefficient, although the benefits associated with 
the science involved are limitless. Successful cloning has the potential to provide newer 
and better biopharmaceuticals, and animal models for human diseases; produce superior 
livestock; save endangered species; and contribute to stem cells research.  
 vi 
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LITERATURE REVIEW 
 
 
Epigenetics 
 
Epigenetics is the study of heritable changes in gene expression due to 
components other than the alteration of the genetic sequence, such as changes to DNA 
methylation marks and modifications to the histone tails (Jaenisch and Bird, 2003). For 
example, the human body has over 200 cell types, with each cell possessing the same 
unique DNA sequence but differing in gene expression. These epigenetic influences aid 
in creating different cell and tissue types by affecting the expression patterns of specific 
genes. Interestingly, genetically identical twins develop different epigenetic markers over 
time. Thus, different phenotypes can stem from identical genotypes (Fraga et al., 2005). 
Some scientists indicate that epigenetic modifications have evolved as a genome defense 
against parasitic and viral sequences (Matzke et al., 1999). During early embryonic 
development, cellular differentiation occurs as a consequence of epigenetic influences on 
the genome. These epigenetic modifications regulate the expression of cell-type specific 
genes. If epigenetics governs the genes associated with each cell and tissue type, then 
somatic cell nuclear transfer (SCNT) is successful only when the donor cell genome can 
be reprogrammed sufficiently to give rise to every cell-type in the resultant organism, 
including extra-embryonic membranes. Incomplete or abnormal epigenetic 
reprogramming of the donor cell genome has been shown to contribute to the low 
efficiency of SCNT and is believed to contribute to the phenotypic abnormalities 
associated with the resultant offspring.    
 One important epigenetic mechanism of gene regulation deals with the chemical 
modification of the histone tails. Histone proteins are an integral part of DNA packaging 
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and chromosome structure. A basic unit of packaged DNA is called a nucleosome, which 
consists of 146 base pairs of DNA wrapped around an octamer of four core histone 
proteins (H3, H4, H2A, and H2B) (Luger et al., 1997). The N-terminus tail of the histone 
protrudes outwardly from the nucleosome and contains multiple modification sites that 
are available for interactions with other proteins. At the N terminus of each histone are 
15-38 amino acids that form the “tails,” which provide multiple sites for post-
translational modifications to the underlying DNA sequence. These modifications include 
acetylation, methylation, ubiquitination, phosphorylation, and sumoylation (Goll and 
Bestor, 2002). Histone modifications are accomplished through the function of nuclear 
enzymes such as histone acetyltransferases (HATs), deacetylases (HDACs), and 
methyltransferases (HMTs). There are a great many potential combinations of 
modifications to the 38 amino acids forming the histone tails. The characterization of the 
biological events associated with each unique combination is daunting, yet some patterns 
have emerged. Knowledge of specific histone profiles will invariably enhance our 
understanding of the reprogramming necessities associated with successful SCNT.  
Specific histone modifications have been shown to be reversible and related to 
gene expression and regulation. Methylation of particular residues of the histone tail is a 
key modification for regulating chromatin packaging and gene expression (Goll and 
Bestor, 2002; Barski et al., 2007). Trimethylated histone H3-lysine 4 (H3K4me3) is 
associated with gene activation, whereas dimethylated histone H3-lysine 9 (H3K9me2) 
and trimethylated histone 3 H3-lysine 27 (H3K27me3) are predominantly linked with 
transcriptional repression. Acetlylation of histone H4 on ysine 16 (H4K16Ac) aids in the 
regulation of chromatin folding and transcriptional activation (Shogren-Knaak et al., 
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2006; Wang et al., 2008; Rosenfeld et al., 2009). While most histone modifications have 
been grouped according to their function to either silence or activate transcription, 
conflicting modifications have also been shown to co-exist. The most notable example 
occurs in the regulatory loci of developmentally important genes in embryonic stem cells 
(ES), where competing modifications co-localize, producing a bivalent domain of both 
activating and repressing modifications (Bernstein et al., 2006; Rugg-Gunn et al., 2010). 
Some researchers have hypothesized that this epigenetic pattern is present in genes where 
a rapid transition between activation and repression would be advantageous, mainly in 
association with embryonic development and determining cell fate (Ku et al., 2008; 
Sevostyanova et al., 2008). 
In connection with cell lineage determination, countless efforts have been made to 
establish the epigenome state that maintains pluripotency. The expression pattern of 
pluripotent cells is unique, and pinpointing the epigenetic mechanisms involved in 
establishing pluripotency will lead to many new biomedical applications, from organ 
regeneration to more efficient SCNT. ES cells are the progenitors to hundreds of cell 
types, and their plasticity is at the heart of the developmental research of today. In 1923 a 
Russian scientist named Maximow was studying the effects of x-rays on inflammation 
and noted how some cells were able to differentiate into other cells and were “endowed 
with great prospective potencies of development” (Maximow, 1923). In 1960 the same 
idea of radiation on mice bone marrow cells fueled experiments that led to the term “stem 
cells” (McCulloch and Till, 1960). In 1981 cells from the inner-cellular mass (ICM) of an 
early mouse embryo were isolated and termed “embryonic stem cells,” and by 1998 a 
group at the University of Wisconsin-Madison was successful in isolating stem cells from 
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human embryos (Martin, 1981; Thomson et al., 1998). In 2007 the Nobel Prize was 
awarded for the knockout mouse project, which gave researchers the ability to study gene 
function in live mice (Austin et al., 2004). Despite some public discomfort on the topic of 
human embryonic stem cells for research, and the multitude of complexities in genomics, 
adult cells can now be reprogrammed into putative stem cells and used in select 
therapeutics to rejuvenate damaged or diseased tissue types.  
The mechanisms and components of establishing a pluripotent state are complex, 
yet they are becoming more defined daily. A hallmark of pluripotency is the presence of 
pluripotent transcription factors (TFs) (Yamanaka and Takahashi, 2006). Namely, Oct4, 
Nanog, and Sox2 are TFs that are hallmarks of establishing a pluripotent state (Yamanaka 
and Takahashi, 2006; Pan and Thomson, 2007).  
The gene Nanog was named by the Scottish professor Ian Chambers as a 
reference to the legendary “Tir Na Nog” land of perpetual youth. In 2003 they classified 
Nanog in the “transcription factor hierarchy that defines ES cell identity” (Chambers et 
al., 2003). Nanog is involved in the self-renewal of pluripotent ES cells and its absence in 
mouse ES cells promotes differentiation (Yates and Chambers, 2005). In primates, 
siRNA was used to knockdown Nanog, which resulted in differentiation of ES cells 
(Yasuda et al., 2006). Nanog has also been shown to work in concert with other TFs 
(Chambers, 2004), although Takahashi and Yamanaka initially produced induced 
Pluripotent Cells (iPS) without citing Nanog as a necessary TF. Nevertheless, Nanog 
remains at the core of epigenetic research today. 
Oct4 is one TF that binds to the “oct”amer sequence ATTTGCAT and is 
synonymous with POU5F1 (Petryniak et al., 1990). The function of Oct4 is well 
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documented. Nichols and coworkers showed that Oct4 mRNA is found in all early 
cleavage stage mouse blastomeres (Nichols et al., 1998). This same group went on to 
report that Oct4 expression transitions specifically to the ICM cells during pre-
implantation embryogenesis. In 2005 RNA interference was used to knockdown Oct4 and 
Nanog, leading to cell differentiation in human ES cells (Zaehres et al., 2005). Oct4-
deficient embryos will develop to blastocyst, however the ICM cells are not pluripotent 
(Nichols et al., 1998). In 2004 Oct4 knockout mice were produced (Kehler et al., 2004). 
This group showed that Oct4 is expressed in the primordial germ cells of mice, and 
knockout of this gene caused apoptosis to the primordial germ cells, resulting in sterility. 
Oct4 was also one of four necessary TFs shown to induce pluripotency by Yamanaka 
(Yamanaka and Takahashi, 2006).  
 Sox2 is another key TF cited by Yamanaka to contribute to pluripotency 
(Yamanaka and Takahashi, 2006). As early as 1995, Sox2 was linked with Oct4. The two 
TFs were observed to form a joint complex that promotes the transcription of Fibroblast 
Growth Factor 4, which is expressed in the ICM of the mouse blastocyst (Yuan et al., 
1995). In 2007 Masui et al demonstrated that inducible Sox2-null ES cells were still able 
to activate the genes previously classified as “Oct-Sox” enhanced. This same group 
identified the regulatory role of Sox2 in Oct3/4 expression, thus demonstrating the main 
function of Sox2 in maintaining appropriate Oct3/4 expression (Masui et al., 2007). Sox2 
and Oct4 also interact with the Nanog promoter, linking these three as essential TFs in 
the mechanisms associated with maintaining pluripotency (Rodda et al., 2005). 
Additional details of these three TFs emerge daily due to their unparalleled role in 
maintaining a pluripotent state. While other genes and factors have also been shown to 
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contribute to the pluripotent state, these three TFs are sufficient representatives of this 
developmentally important state for the present study. 
 
History of Cloning 
 The nuclear transfer (NT) process was first proposed by Hans Spemann, the 
German Nobel Laureate, in 1938, although he lacked the necessary equipment to 
sufficiently test the hypothesis (Spemann, 1938). Cloning by NT involves removing the 
DNA (enucleation) from an unfertilized oocyte, followed by the addition of foreign DNA 
to the enucleated oocyte (cytoplast), yielding a zygote with a full compliment of DNA 
that is capable of producing a living organism. Although the concept of manually 
removing the oocyte DNA and replacing it with another cell’s DNA appears relatively 
simple, the molecular mechanisms involved in remodeling and reprogramming the donor 
cell genome after entry into the cytoplasm of the cytoplast remain somewhat complex 
and undefined.      
In 1952 Briggs and King successfully produced a Northern Leopard Frog using 
the NT process (Briggs and King, 1952). This same group later concluded that NT 
embryos produced using cells from more developed embryos had increasingly poor 
developmental potential (King and Briggs, 1956). Multiple somatic cell types, or non-sex 
cells from the body of an organism, were used in many of the first SCNT attempts in 
frogs. These somatic cell sources included lymphocytes (Wabl et al., 1975), skin (Gurdon 
et al., 1975), erythrocytes (Di Berardino and Hoffner, 1983), and erythroblasts and 
leukocytes erythroblasts (Di Berardino and Orr, 1992). These experiments yielded 
tadpoles that were normal morphologically, proving that some somatic cell types are 
capable of de-differentiating. Although successful, no adults were produced.  
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By the 1980’s, scientists studying mammalian developmental biology began using 
the NT method to generate embryos. Some of the first experiments involved mice, where 
pronuclei were transferred to enucleated zygotes (McGrath and Solter, 1984). This same 
experiment resulted in live births from embryos produced using pronuclei, but failed to 
produce live births using nuclei from the two-cell, four-cell, eight-cell, or ICM. Live NT 
lambs were produced using eight and sixteen-cell blastomeres as nuclear donors in 1986 
(Willadsen, 1986). This work was followed in 1987 by the birth of the first NT cattle 
(Robl et al., 1987). Mice, rats, goats, monkeys, rabbits, and pigs were also produced 
using cells from preimplantation embryos (Di Berardino, 2001). Although using these 
embryonic cells proved successful, NT imploring stem cell-like donor cells was not 
(Tsunoda and Kato, 1993; Stice et al., 1996). In 1994 Sims and First produced cloned 
calves by transferring inner cell mass (ICM) cells that had been cultured in vitro for up to 
28 days (Sims and First, 1994). In summary, NT mammalian clones were produced using 
pronuclei, giving rise to the use of cells from preimplantation embryos, which was then 
followed by the use of cultured ICM (differentiated) cells, and all of this work ultimately 
led to the use of an adult cell (mammary) and the birth of Dolly (Wilmut et al., 1997). 
Using donor cells from mammary tissue was not particularly advantageous, however they 
were differentiated-adult cells. Dolly’s birth has been followed by the live birth of many 
mammalian species using NT of somatic cells including ferrets (Li et al., 2006b), dogs 
(Lee et al., 2005), horses (Galli et al., 2003), cats (Shin et al., 2002), rats (Zhou et al., 
2003), rabbits (Chesne et al., 2002), mules (Woods et al., 2003), pigs (Polejaeva et al., 
2000), goats (Baguisi et al., 1999), cattle (Wells et al., 1999), and mice (Kishigami et al., 
2006). Results of these experiments show that the unfertilized oocyte contains the 
 8 
components necessary to take a terminally differentiated somatic cell and reverse the 
differentiating process sufficiently to produce the many different cell types of a complex 
organism. Although the use of adult somatic cells has been successful, attempts to use 
stem cell-like lines in the NT process are less effective (Sung et al., 2006). This reduced 
efficiency using adult stem cells is puzzling, and more research is needed to fully 
characterize the molecular factors associated with the donor cell’s epigenetic state that 
will give rise to the most successful SCNT outcome.    
The proficiency of the SCNT process coupled with the percentage of SCNT 
pregnancies that result in the birth of live offspring reveals that there is room to refine the 
overall process. Aside from the many different protocols in embryo transfer, cell culture, 
and data representation, to say nothing of the differences that may arise from the bos 
taurus gene pool potpourri, less than 5% of transferred cloned embryos result in live 
births (Oback and Wells, 2003). Determining the specific deficiencies present in the other 
95% of transferred failed SCNT embryos is daunting, yet specific abnormalities have 
been identified. One such deficiency is abnormal placentation and enlarged placentomes 
(Constant et al., 2006). Others cite epigenetic abnormalities in the cloned embryo, 
including improper DNA methylation and aberrant histone modifications as possible 
hurdles for proper embryonic development (Arney et al., 2001; Reik et al., 2001; Santos 
and Dean, 2004; Steele et al., 2005; Eilertsen et al., 2007). The multiplicity of 
mechanisms occuring during normal embryogenesis and development is overwhelmingly 
complex, yet the generation of live offspring from SCNT proves that sufficient successful 
epigenetic reprogramming and subsequent development is possible.  
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The research presented in this Master’s Thesis combines three pluripotent TFs 
(Nanog, Oct4, and Sox2) with four well-defined histone modifications (H3K4me3, 
H3K9me2, H3K27me3, and H4K16Ac) and examines their regulatory role associated 
with gene expression following SCNT in the bovine blastocyst. The main objective in 
this undertaking was to determine any abnormalities with the four histone modifications 
listed above and their association to Nanog, Oct4, and Sox2, and how these abnormalities 
affect gene expression and ultimately protein levels. We hypothesized that the histone 
modification profiles in SCNT embryos associated with these genes will more closely 
resemble that of the donor cell. Further we postulated that the failure to completely 
reprogram the donor cell will lead to altered gene expression and protein levels. The new 
knowledge obtained from these studies will help identify the epigenetic differences that 
might be associated with these three genes in a cloned blastocyst and demonstrate how 
those abnormalities affect the expression of these developmentally important genes.        
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INTRODUCTION 
 
Since the birth of Dolly in 1997, SCNT has been successful in producing live 
offspring in a number of different species. The benefits of the nuclear transfer technology 
extend far beyond producing animals, and new applications for the science continue to 
emerge. Live births from SCNT provide excellent evidence that the oocyte contains the 
components necessary to transform an adult cell into a stem cell state and ultimately 
differentiate into all of the cell types required to produce viable offspring. The molecular 
mechanisms involved in this transformation are currently undefined, and tremendous 
effort is being expended to better characterize this phenomenon. Although SCNT is 
successful, the percentage of SCNT embryos that result in live and healthy offspring is 
quite low. Only 5-10% of transferred bovine embryos result in live births (Oback and 
Wells, 2007). These percentages leave substantial opportunity for improvement, and a 
correct understanding of the mechanisms associated with this cellular transformation 
should not only improve efficiency and live birth rates, but will further enhance the 
broader applications of this technology.  
One of the proposed inefficiencies of the SCNT process is associated with what 
has been referred to as nuclear reprogramming. Although the oocyte has the capacity to 
program a fertilizing sperm nucleus during traditional fertilization, incomplete 
reprogramming of the differentiated donor-cell nucleus has been cited as a key factor for 
the low success rate of SCNT (Bourc'his et al., 2001; Beyhan et al., 2007). Specifically, 
the differences between SCNT and traditionally fertilized embryos in DNA methylation 
and histone modifications are documented abnormalities (Bourc'his et al., 2001; Kang et 
al., 2002; Enright et al., 2003). These epigenetic irregularities are typically accompanied 
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by a concomitant aberrant gene expression profile in SCNT embryos (Bortvin et al., 
2003; Smith et al., 2005; Li et al., 2006a; Beyhan et al., 2007). Other irregularities in 
SCNT between pregnancy establishment and birth include hydro allantois (Lawrence et 
al., 2005), respiratory distress, stillbirth (Hill et al., 1999), and abnormal placentation 
(Constant et al., 2006). Abnormalities in gene expression and overall development are 
certainly manifestations of earlier anomalies, and pinpointing normal and necessary 
epigenetic components is a necessary step in correcting these irregularities.  
While some scientists attempt to trace the mechanisms associated with normal 
gene expression and development, others have successfully pursued the reverse approach, 
whereby an adult cell is reprogrammed into an embryonic-like stem cell without exposure 
to the cytoplasmic environment of the unfertilized oocyte. The mechanisms of 
establishing a stem cell state are complex, but some hallmarks do exist. Yamanaka and 
Takahashi found that introducing four transcription factors (Oct3/4, Sox2, c-Myc, and 
Klf4) to fibroblast cultures resulted in pluripotent stem cells (Yamanaka and Takahashi, 
2006). Another important factor, Nanog, was later shown to act in concert with Oct4 and 
Sox2 as down-stream regulators on other genes apparently important to establishing a ES 
cell state (Pan and Thomson, 2007). These TFs work together to properly regulate their 
own expression levels, ultimately maintaining stem cell-type characteristics.  
In the present study, we sought to better understand the inefficient process of 
SCNT, the epigenetic irregularities in SCNT embryos, the importance of Nanog, Oct4 
and Sox2 in establishing and maintaining ES cells, and the potential associated with 
refining the SCNT process. Specifically, we set out to characterize the effect of four 
histone modifications on the gene expression of three pluripotent TFs in the bovine 
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blastocyst and define any irregularities that are present in SCNT embryos. A correct 
characterization of the epigenetic mechanisms associated with reprogramming adult cells 
into embryonic cells will further propel the application of the stem cell biology. 
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RESULTS 
 
µChIP 
 
The three genes in question (Nanog, Oct4, and Sox2) and their association with 
four histone modifications (H3K4me3, H3K9me2, H3K27me3, and H4K16ac) and with 
four DNA sources (donor cells, IVF, SCNT, and trophoblast cells) were analyzed using a 
two-way ANOVA comparison. Results within each gene and histone modification were 
compared across all cell types, and many significant differences were apparent. Broadly, 
these histone modifications are only minimally associated with the three genes in 
question in trophoblast cells, with five data points less than 1%, and the other seven 
trophoblast data points below 16% of the total. We were not able to detect association of 
Oct4 with any of the histone modifications in question in any cell type, with the highest 
percentage of the total being 9% in trophoblast cells.  
 Two-way ANOVA followed by Bonferroni’s post-hoc means test further 
classified the interaction and variance in the samples. This test accounted for the variance 
due to the DNA source, the gene, and the interaction between the DNA source and the 
gene. Analysis of each histone modification showed that the DNA source accounted for 
the highest percentage of the variance seen, specifically 42% in H3K4me3, 31% in 
H3K9me2, 36% in H3K27me3, and 38% in H4K16ac. The effect of the gene and the 
interaction between the gene and DNA source both accounted for less than 25% of the 
variance seen with each modification.  
H3K4me3 showed significant differences between donor cells, IVF, and SCNT in 
Nanog, where 46% of SCNT DNA and only 10% of IVF DNA was precipitated. 
Differences in Sox2 were seen in the same cell types, where again half of SCNT DNA 
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and 25% of IVF DNA were pulled down. We obtained a similar pattern with H4K16ac 
that we observed with the related H3K4me3 modification, and both are associated with 
transcriptional activation. In evaluating Nanog, 60% of SCNT and 20% of IVF DNA was 
precipitated, and 30% of both DNA sources were precipitated in Sox2.  
The two histone modifications associated with repressing transcription, H3K9me2 
and H3K27me3, exhibited similar patterns in both Nanog and Sox2 in regards to IVF, 
donor cells, and SCNT samples. In fact, both repressive and activating modifications 
exhibit somewhat similar patterns of association with all three genes evaluated, rather 
than observing an inverted pattern. This pattern is consistent with other published reports, 
where bivalent domains are present in developmentally important genes (Rugg-Gunn et 
al., 2010). Our initial hypothesis was that the donor cells used in SCNT experience 
incomplete reprogramming, and that the histone profiles of the resultant cells from SCNT 
embryos would more closely resemble the profiles of the donor cell. These results clearly 
indicate that the reprogramming associated with these four histone modifications and 
three genes is incomplete in relation to some genes and modifications, and adequate in 
relation to others. The histone profiles of SCNT embryos resemble those of the donor cell 
in some instances, yet in other locations are similar to the IVF control embryos.   
 
 
 15 
 
FIGURE 1.  Association of DNA with Histone 3 Lysine 4 tri-methyl (H3K4me3). Values 
represent the average of four independent µChIP assays using 10 day-7 blastocysts or 
1,000 cells, normalized by the amount of input DNA. Different superscripts within 
individual genes represent significant differences (P<0.05) as determined by two-way 
ANOVA with Bonferroni post-hoc test comparisons. This histone modification is 
associated with transcriptional activation.  
 
 
FIGURE 2.  Association of DNA with Histone 4 Lysine 16 acetylation (H4K16ac). 
Values represent the average of four independent µChIP assays using 10 day-7 
blastocysts or 1,000 cells, normalized by the amount of input DNA. Different 
superscripts within individual genes represent significant differences (P<0.05) as 
determined by two-way ANOVA with Bonferroni post-hoc test comparisons. This 
histone modification is associated with transcriptional activation.  
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FIGURE 3. Association of DNA with Histone 3 Lysine 9 di-methyl (H3K9me2). Values 
represent the average of four independent µChIP assays using 10 day-7 blastocysts or 
1,000 cells, normalized by the amount of input DNA. Different superscripts within 
individual genes represent significant differences (P<0.05) as determined by two-way 
ANOVA with Bonferroni post-hoc test comparisons. This histone modification is 
associated with transcriptional repression.  
 
 
 
FIGURE 4.  Association of DNA with Histone 3 Lysine 27 tri-methyl (H3K27me3). 
Values represent the average of four independent µChIP assays using 10 day-7 
blastocysts or 1,000 cells, normalized by the amount of input DNA. Different 
superscripts within individual genes represent significant differences (P<0.05) as 
determined by two-way ANOVA with Bonferroni post-hoc test comparisons.  This 
histone modification is associated with transcriptional silencing.  
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Gene Expression 
 
The expression of Nanog, Oct4, and Sox2 were analyzed in IVF and SCNT 
blastocysts (Figure 5). Three pools of each embryo type were analyzed. After computing 
!!Ct values and identifying the fold change in expression, significantly (P<0.05) higher 
levels of Oct4 were present in IVF than SCNT blastocysts. Expression of Nanog and 
Sox2 in SCNT blastocysts did not differ significantly compared to IVF controls 
(P=0.2916, P=0.2417 respectively).  
 
 
FIGURE 5. Delta-Delta Ct values for RT-PCR. Values represent the average of three 
replicates, where RNA was extracted from a pool of 10 day-7 blastocysts. Asterisk 
indicates significant difference (P=0.0402), as determined by the Student’s t-test.  
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Protein Analysis 
 Embryos were imaged using a 20x plan-APO objective. The AxioVision software 
was used to quantify the fluorescence seen in the stained embryos. This calculation 
included the total number of pixels in the image that were stained positive for DAPI, 
divided by the total number of pixels positive for each fluorescent tag. Thus the amount 
of nuclei in each embryo that contain the protein of interest is expressed as a percentage 
of the total number of nuclei. The student’s t-test was applied to these percentages, and 
the average percentages of ten embryos for each protein and embryo type is represented 
in Table 6. On average, IVF blastocysts contained a higher percentage of positive nuclei. 
Of the TFs in question, only Oct4 was considered significantly different in SCNT 
blastocysts, with a P-value of 0.0119. Nanog and Sox2 values were similar, with P-values 
of 0.4416 and 0.5847. This quantitative data (Figure 11) is supported visually by the 
images produced below (Figures 6-10). This protein expression pattern also coincides 
with the mRNA results discussed previously. 
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Figure 6.  Nanog staining in IVF and SCNT blastocysts. Images are representative of 
Nanog in IVF (A-C) and SCNT (D-F) blastocysts. Ten embryos were imaged for each 
type (IVF or SCNT) and protein (Nanog, Oct4, or Sox2). These images are indicative of 
the average percentage of nuclei positive for Nanog in IVF (44%) and SCNT (40%), 
calculated by dividing the total # of pixels positive for DAPI (A, D) by the total # of 
pixels positive for the antibody/fluorophore (B, D). The light blue color created by the 
merged images (C, F) indicates the presence of Nanog in the nuclei of the embryonic 
cells, and most positive cells are in the ICM. Results of the statistical analyses of 
immunofluorescence data are provided in Figure 11. 
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FIGURE 7.  Oct4 staining in IVF and SCNT blastocysts. Images are representative of 
Oct4 in IVF (A-C) and SCNT (D-F) blastocysts. Ten embryos were imaged for each type 
(IVF or SCNT) and protein (Nanog, Oct4, or Sox2). These images represent the average 
percentage of nuclei positive for Oct4 in IVF (46%) and SCNT (32%) calculated by 
dividing the total # of pixels positive for DAPI (A, D) by the total # of pixels positive for 
the antibody/fluorophore (B, D). The light blue present in the merged images (C, F) 
indicates the presence of Oct4 in the nuclei of the embryonic cells, and most positive 
cells are in the ICM. Results of the statistical analyses of immunofluorescence data are 
provided in Figure 11. 
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FIGURE 8.  Sox2 staining in IVF and SCNT blastocysts. Images are representative of 
Sox2 in IVF (A-C) and SCNT (D-F) blastocysts. Ten embryos were imaged for each type 
(IVF or SCNT) and protein (Nanog, Oct4, or Sox2). These images represent the average 
percentage of nuclei positive for Sox2 in IVF (43%) and SCNT (40%) calculated by 
dividing the total # of pixels positive for DAPI (A, D) by the total # of pixels positive for 
the antibody/fluorophore (B, D). The pink color in the merged images (C, F) indicates the 
presence of Sox2 in the nuclei of the embryonic cells, and most positive cells are in the 
ICM. Results of the statistical analyses of immunofluorescence data are provided in 
Figure 11. 
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FIGURE 9. Sox2 and Oct4 in IVF and SCNT blastocysts. Images show co-localization in 
IVF (A-D) and SCNT (E-H) blastocysts of Sox2 (B, F) and Oct4 (C, G).  
 
 
 
 
FIGURE 10. Negative control performed with non relevang Ig. Images show Hoechst 
(A), non relevant IgG and Alexa Fluor 488 (B) and merged (C).   
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Figure 11.  Immunofluorescence and protein analysis. Data was normalized by dividing 
the total number of positive pixels for DAPI by the total number of positive pixels 
containing each antibody/fluorophore in each image. Values represent the average of ten 
day-7 blastocysts and an asterisk represents significant difference (P=0.012), as 
determined by the Student’s t-test.  
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DISCUSSION 
 This study provides a comparative analysis of prominent histone modifications 
and their effect on the expression of three key pluripotent genes. The ability to follow the 
histone profiles of the donor cell from fibroblast to SCNT blastocyst is unique to this 
model. This study represents the first attempt to couple the association of these histone 
modifications in these three genes with a quantification of the relative protein expression 
in the bovine model. The histone patterns of SCNT embryos mimic both those seen in the 
donor cells and IVF embryos, indicating a reprogrammed hybrid of the progenitor 
fibroblast and the typical developing blastocyst. Thus, the hypothesis that SCNT 
blastocysts would retain histone modification profiles resembling those of donor cells 
instead of control IVF blastocysts was correct for some loci, whereas other loci acquired 
the modifications observed in appropriately programmed IVF embryos.   
 Significant differences in the percentage of DNA associated with each of the four 
histone modifications examined were observed when comparing DNA obtained from the 
donor cell to that from SCNT embryos. IVF and SCNT profiles were similar for the Sox2 
gene and its association with three of the four histone modifications we examined. 
Similarly in Nanog, three of the four histone modification profiles of IVF embryos 
resembled those of the donor cells. Other observations from our group illustrate the role 
of DNA methylation in regulating the expression of these three genes (Davis et al., 
unpub. obs). Specifically, the methylation patterns in SCNT blastocysts observed in 
Nanog and Sox2 were more similar to the methylation patterns in the donor cells than 
blastocysts produced via IVF. Oct4 was de-methylated in SCNT blastocysts, in apparent 
contrast to the methylation observed in IVF controls. In our study, Oct4 regulation was 
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not associated with any of the four histone modifications studied in any cell type 
analyzed. We should point out, however, that these four histone modifications represent a 
fraction of the documented modifications associated with epigenetic regulation. Various 
other histone modifications could play a role in the regulation of Oct4. 
Trophoblast cells were analyzed in an effort to differentiate between embryonic 
chromatin from the ICM and the trophectoderm. The histone profiles observed in the 
trophoblast cells did not show any significant association with the genes in question, 
confirming that these three active genes are more closely associated with the ICM cells 
(Stice et al., 1996; Roberts et al., 2004; Bernstein et al., 2006). The immunofluorescence 
data presented here also confirms that these three TFs are primarily localized to the ICM 
of the blastocyst.  
Other researchers have utilized ChIP assays to examine the epigenetic 
components of gene regulation for Nanog, Sox2, and Oct4. In mouse ES cells, Nanog and 
Sox2 loci have large regions of association with H3K4me3 (Mikkelsen et al., 2007). 
Another group examined the effect of acetylation of histone H3K9 and K27 on genes 
associated with regulating cell growth, immune response, and signal transduction in 
bovine cells (Shin et al., 2012). Sox2 and Nanog have also been shown to be 
overexpressed the ICM of bovine blastocysts, yet Oct4 expression did not differ 
significantly between ICM and trophoblast cells (Ozawa et al., 2012). Oct4 is also 
expressed by all cells in the mouse embryo between the 1-cell and late-blastocyst stage 
(Dietrich and Hiiragi, 2007; Plachta et al., 2011). Bovine fibroblast cells infected with 
retroviral Oct4 vectors and used in SCNT produced blastocysts with higher levels of 
histone H3K9 and K27 trimethylation than control blastocysts, yet Sox2 and Nanog 
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expression levels were not altered significantly in the SCNT blastocysts (Goissis et al., 
2013).   
Nanog, Oct4, Sox2, and other transcription factors, are associated with H3K4me3 
and H3K27me3 in mouse ES cells, creating bivalent domains of activating and repressing 
histone modifications (Fouse et al., 2008). The global distributions of H3K4me3 and 
H3K9me2 have been compared between bovine fibroblasts, IVF, and SCNT embryos, yet 
both types of blastocyst-stage embryos showed no significant differences (Wu et al., 
2011). Histone modification profiles are gene, tissue, and age specific, yet combinations 
have been shown to act cooperatively to prepare the chromatin for its transcriptional fate 
(Wang et al., 2008). Nevertheless, such differences in histone profiles associated with 
these pluripotent dependent genes in developing embryos were not anticipated. These 
differences in histone patterns add to the complexity of the events associated with nuclear 
reprogramming and the epigenetic mosaics associated with gene regulation. 
The pattern of aberrant epigenetic regulation detected in bovine blastocysts, 
coupled with similar mRNA levels in two of the three genes in question, agrees with 
findings of other studies. In particular, global gene expression profiles in bovine SCNT 
embryos have been shown to differ significantly at the eight and sixteen cell stage (Smith 
et al., 2005; Aston et al., 2009). However, by the blastocyst stage, the gene expression 
differences between fertilized and cloned embryos had narrowed. This pattern suggests 
that more time during development is needed for the SCNT embryo to produce an 
expression profile similar to conventionally fertilized embryos. Aston et al. (2010) also 
determined that Oct4 expression in bovine IVF blastocysts was significantly different 
from SCNT blastocysts (Aston et al., 2010). The correlation found between the mRNA 
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levels and the protein expression is obviously self-validating, however post-translational 
modifications could play a role in rectifying the aberrant expression of Oct4 in SCNT 
embryos. The fact that these three TFs act in concert to regulate the expression of other 
key pluripotent factors, along with their role in controlling other downstream genes 
important to pluripotency, adds to the complexity of the regulatory network associated 
with embryonic stem cells (Pan and Thomson, 2007). Understandably, any deficiencies 
regarding any of the key-components in this pluripotent network should impact 
embryonic developmental success. Although Nanog and Sox2 expression levels are 
similar in SCNT and IVF embryos, aberrant Oct4 expression could markedly inhibit 
successful development due to its role in working synergistically with other important 
TFs.  
These three genes represent important hallmarks associated with an embryonic 
stem-cell state. The data presented here pinpoints benchmarks relative to nuclear 
reprogramming and successful SCNT. The fact that a terminally differentiated fibroblast 
cell can be successfully reprogrammed and give rise to a competent embryo and 
subsequent offspring confirms the unique capacity of the components found within the 
unfertilized oocyte. Although deficiencies still exist, future studies will continue to 
provide insight into the epigenetic mechanisms involved in SCNT. A complete 
understanding and rectification of any aberrant mechanisms during development will 
yield exponential benefits to the fields of reproductive biology, cancer research, and stem 
cell biology.  
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MATERIALS AND METHODS 
 
Oocyte Collection and Maturation 
 
Bovine oocytes were collected and matured according to the published practices 
of our laboratory (Li et al., 2004). Specifically, bovine ovaries were collected from a 
local abattoir (EA Miller, Hyrum, UT) and cumulus oocyte complexes (coc) were 
aspirated from 3-8 mm follicles using an 18-gauge needle connected to a 50-ml 
centrifuge tube and a vacuum pump. Oocytes with multiple cumulus cell layers were 
washed four times in PB1+ (phosphate-buffered saline with Ca2+, Mg2+, 5.55 mM 
glucose, 0.32 mM sodium pyruvate, and 3mg/ml BSA). The oocytes were then 
transferred in groups of 50 to 500 "l of M199 with 10% FBS, 0.5 "g/ml FSH, 5 "g/ml 
LH, 100 "g/ml streptomycin, and 100 units/ml penicillin. Nunc 4-well IVF dishes (Nunc, 
Milwaukee, WI) were used as culture dishes, and the oocytes were incubated for 22-24 hr 
in 5% CO2 at 39oC.  
 
IVF Embryo Production 
 
Following maturation, oocytes were fertilized with cryopreserved semen 
(Hoffman AI, Logan, UT). Live sperm was separated using a 45/90% percoll gradient, 
placed in fert-TALP and capacitated with a heparin concentration of 10 "g/ml (Reed et 
al., 1996). Diluted sperm was aliquoted to Nunc 4-well IVF dishes with groups of 50 
mature oocytes in 500"l, and allowed to incubate for 18h in 5% CO2 at 39oC. Following 
this incubation the oocytes were placed in 1 ml PB1+ and 10 mg/ml hyalurondase, 
vortexed for 2 min and 40 sec, washed in microdrops of PB1+ and cultured in CR2 media 
in groups of 50 (Rosenkrans and First, 1994). Culture media was supplemented with 200 
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"l of fresh CR2 every 48 hr, and day 7 blastocysts were used in groups of 10 according to 
the needed procedures.   
 
SCNT Embryo Production 
 
 Following maturation, cumulus cells were removed as described above. Oocytes 
with a first polar body were selected. The first polar body and metaphase plate were 
enucleated, and single fibroblast cells were transferred into the perivitelline space of the 
enucleated oocytes. Fusions were done in mannitol fusion medium (Wells et al., 1999)by 
two electric DC pulses of 2.2 kV/cm for 25 "sec. Embryos were then held in CR2 
medium for 1-2 hr prior to activation. Fused embryos were activated between 23 and 25 
hr from the onset of maturation by exposure to 5 "M ionomycin for 5 min followed by 5 
hr incubation in 10 "g/ml cyclohexamide. An equal number of blastocysts were produced 
via SCNT as were used in IVF control groups "ChIP, RT PCR, and 
immunohistochemistry assays.  
 
!ChIP Chromatin Preparation 
 
 Each "ChIP assay required chromatin from around 1,000 cells or 10 expanded 
blastocysts. This protocol was developed by Dahl and Collas, and adapted to 
accommodate DNA obtained from a low number of bovine embryos (Dahl and Collas, 
2008). Briefly, a group of 10 blastocysts were selected and suspended in 500 "l PBS and 
20mM Na-butyrate in a 0.6 ml tube at room temperature. Na-butyrate is used to avoid 
artefactual histone hyper-acetylation (Dahl and Collas 2008). Formaldehyde was added at 
1% vol/vol final concentration to cross-link the DNA to the histone proteins located 
within 2 Angstroms of DNA. 57 "l of 1.25 M Glycine was used to quench the 
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formaldehyde at room temp for 5 min. Cells were centrifuged at 470 x g for 10 min at 
4°C in a swing-out rotor. The supernatant was aspirated and discarded, leaving 30 "l of 
the solution with the pellet. The cells were then resuspended in 500 "l ice cold PBS/Na-
butyrate by gentle vortexing and centrifuged again at 470 x g for 10 min at 4°C as before. 
This washing procedure was repeated twice. Upon aspiration of the last wash, about 20 "l 
of the PBS/Na-butyrate was left with the pellet.  
 After washing, 200 "l lysis buffer (50mM Tris-HCl pH to 8.0, 10 mM EDTA, 1% 
wt/vol SDS, 1 mM PMSF, 1 mM Protease Inhibitor, and 20 mM Na-butyrate) was added 
at room temperature, vortexed twice for 5 sec and put immediately on ice. PMSF, 
protease inhibitor, and Na-butyrate were added just before use to all working solutions. 
After at least 5 min on ice, the samples were sonicated using the 550 Sonic Dismembrator 
(Fisher Scientific) for 7 x 30 sec, with 2-min pauses on ice between each 30-sec session. 
With the 550 Sonicator, the cycle was set to 0.5 and intensity was set to 30% power. 
Sonication produced chromatin fragments of 500 base pairs. 100 "l RIPA ChIP buffer 
(10 mM Tris-HCl pH to 7.5, 140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% vol/vol 
Triton X-100, 0.1% wt/vol SDS, 0.1% wt/vol Na-deoxycholate, 1 mM protease inhibitor 
mix, 1mM PMSF, 20 mM Na-butyrate) was added following sonication, and mixed by 
vortexing. Samples were then centrifuged at 12,000 x g for 10 min at 4°C and the 
supernatant (chromatin) was aspirated and transferred to a 1.5 ml tube chilled on ice. 
Another 100 "l RIPA ChIP buffer was added to the remaining pellet and mixed by 
vortexing, followed by centrifugation at 12,000 x g for 10 min at 4°C and aspiration of 
the supernatant. This yielded 420 "l chromatin suitable immediately for ChIPs or stored 
at -80°C for up to 2 months (prolonged storage has not been tested).    
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!ChIP Antibody-bead Complexes 
 A slurry of Dynabeads Protein A (Invitrogen, Carlsbad, CA) was prepared using 
11.25 "l Dynabead stock solution/ChIP. Each assay included one ChIP as a negative 
control and one ChIP for each gene of interest. The total Dynabead solution was placed in 
a 0.6 ml-tube and placed in a magnetic rack where the beads were captured and the buffer 
was removed and discarded. The beads were then washed 3 times by adding 400 "l RIPA 
buffer (10 mM Tris-HCl pH to 7.5, 140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% 
vol/vol Triton X-100, 0.1% wt/vol SDS, 0.1% wt/vol Na-deoxycholate) vortexed, 
recaptured in the magnetic rack, and the RIPA discarded. After the final wash 11 "l 
RIPA/ChIP was added, the tube was vortexed and placed immediately on ice. An 8-tube-
strip of 0.2 ml PCR tubes was used for subsequent steps to facilitate handling. One tube 
per ChIP was used, and each tube received 90 "l RIPA buffer, 10 "l washed Dynabeads, 
and 2.4 "g antibody. Negative controls received either no antibody or a preimmune 
antibody. The tube strip was then placed on a rotator at 40 r.p.m. for 2 hr at 4 °C. After 
incubation the antibody-bead complexes were captured using the magnetic rack, the 
RIPA was then removed, 100 "l prepared chromatin from above was added, the beads 
were released and mixed by gentle agitation and finally placed on a rotator at 40 r.p.m. 
for 2 hr at 4 °C. Following incubation, the tubes were centrifuged briefly in a mini 
centrifuge to bring down liquid trapped in the lids and placed on the magnetic rack. The 
beads and precipitated chromatin were then washed three times by gently aspirating and 
discarding the supernatant, adding 100 "l of ice-cold RIPA buffer, gently agitating and 
four minutes on a rotator at 40 r.p.m. at 4 °C. After the final wash and removal of the 
supernatant, 100 "l of TE buffer was added, followed by another 4 min on the rotator at 
 32 
40 r.p.m. at 4 °C. The contents of each tube were transferred to a clean 0.2 ml tube 
chilled on ice, and the tubes were placed in the magnetic rack where the chromatin-bead 
complexes were captured again. The TE was subsequently removed, and 40 "l of Chelex-
100 (Bio-Rad Laboratories, Hercules, CA) was added to each tube and vortexed for 10 s. 
100 "l of prepared chromatin was also placed in a 0.6-ml tube as an input sample, and 
both input and "ChIP samples were processed as outlined below. 
 
Purification of Input and Precipitated Chromatin 
 
To the input chromatin sample 10 "l acrylamide carrier and 250 "l of 96% 
ethanol at -20 °C were added. After thorough vortexing, the sample was placed at -80 °C 
for 30 min. The sample was then thawed and centrifuged at 20,000g for 15 min at 4 °C. 
Following centrifugation, the supernatant was aspirated and discarded, and the pellet was 
washed in 500 "l of 70% ethanol. To the dried pellet 40 "l of Chelex-100 was added and 
the sample was vortexed for 10 sec.  
 All samples containing Chelex-100 were boiled for 10 min and then cooled to 
room temperature. Proteinase K (1 "l, Qiagen, Valencia, CA) was added, and each tube 
was vortexed for 10 s and incubated at 55 °C at 1,300 r.p.m. for 30 min. The samples 
were then boiled again for 10 min and centrifuged for 10 sec. 30 "l was aspirated and 
transferred using a silicon tip to a clean 0.6 ml tube chilled on ice. 20 "l of molecular 
grade water was added, and each tube vortexed 2 x 10 sec and then centrifuged for 10 
sec. Another 15 "l of supernatant was transferred to the corresponding 0.6 ml tube 
yielding 45 "l of precipitated DNA. Careful consideration was taken to ensure that no 
beads were aspirated and that each tube of purified DNA contained equal volumes to 
maintain consistency.  
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Quantitative PCR 
 SYBR Green real-time PCR (Abgene, Rochester, NY) was used to quantify the 
precipitated DNA. Each real-time PCR reaction was performed in duplicate on clear 96-
well plates. Individual 25 "l real-time PCRs were prepared for all "ChIP and input 
samples with each primer pair. Each reaction consisted of 12.5 "l MaximaTM SYBR 
Green 2X qPCR Master Mix (Fermentas, Glen Burnie, MD), both forward and reverse 
primers at 200 nM final concentration, 5 "l template DNA, and 5.5 "l molecular grade 
water. The same PCR program was used for each primer set: 15 min at 95 °C for 
activation of MaximaTM Hot Start Taq DNA polymerase, followed by 40 cycles of 95 °C 
for 30 sec, 60 °C for 20 sec, and 72 °C for 30 sec and data acquisition. A standard curve 
was generated for each primer set using genomic DNA prepared with the positive control, 
allowing Ct values to be converted to ng of DNA. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as the housekeeping gene, and primers (Table 1) 
were designed using Primer3 software.  
 
Table 1. Primers used for µChIP PCR 
________________________________________________________________________ 
Gene   Direction  Sequence____________________________ 
Sox2   Forward  TTTCACGTTTGCAACTGTCC 
Reverse  CATCACCCACAGCAAATGAC  
 
Nanog   Forward  CCCTAGAGTTGGATGCTTCG 
Reverse  CATTGGACTGGATGGCTCTT 
 
Oct4    Forward  GTTTTGAGGCTTTGCAGCTC 
Reverse  TCTCCAGGTTGCCTCTCACT 
 
GAPDH  Forward  CCAACGTGTCTGTTGTGGATC 
Reverse  GAGCTTGACAAAGTGGTCGTT 
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RNA Extraction and Reverse Transcription 
  
SCNT and IVF 7-day blastocysts were pooled in groups of 10, and an RNA easy 
kit was used to extract total RNA (Qiagen, Valencia, CA). Embryos were snap-frozen 
and resuspended in beta-mercapto ethanol and RLT buffer. After following the Qiagen 
protocol, cDNA was produced using Superscript® III Reverse Transcriptase (Invitrogen, 
Carlsbad, CA). 50 ng of random primers were used, and this cDNA served as the 
template in RT-Q PCR. Each primer set (Table 2) followed the same PCR protocol: 95 
°C for 10 min, and then 40 cycles of 95 °C for 30 sec, 60 °C for 20 sec, and 72 °C for 30 
sec. Each 15 "l reaction contained ABgene SYBR Green Master Mix (Thermoscientific, 
Waltham, MA), 200 nM forward and reverse primers, and 2 "l of template.  
 
Table 2. Primers used for gene expression analysis 
________________________________________________________________________ 
Gene   Direction  Sequence____________________________ 
Nanog   Forward  ATGTTTGAAGAAAGTTAYGTGTT 
Reverse  ATACCATCTCTAACACACCTT 
 
Oct4    Forward  GTTAGAGGTTAAGGTTAGTGGG 
Reverse  CATCCCTCCACACAAATCATAAAAC 
 
Sox2   Forward  TAAGAGAGTGGAAGGAAATTTAG 
Reverse  CACAAATACAAACCAAACAAAAC  
 
 
Immunohistochemistry  
  
Protein levels were analyzed using immunofluorescence. SCNT and IVF 7-day 
blastocysts were produced as described, and a Fixation/Permeabilization kit from 
eBioscience (eBioscience SanDiego, CA) was used for protein fixation, membrane 
permeabilization, blocking agent, and antibody diluent. Nunc 4-well IVF dishes with 500 
"l of solution were used for all dilutions and incubations with no more than five 
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blastocysts per well. Embryos were fixed with a working solution of 1-part fixation 
solution and 3-parts of the supplied diluent and incubated @ 4°C for 1 hr in the dark. 
Embryos were then washed twice in a working solution of permeabilization buffer (1-part 
supplied permeabilization media, 9-parts H2O, and 2% normal mouse serum). This 
permeabilization working solution was used for each subsequent step. A volume of 1 "l 
of primary antibody was added to 500 "l of permeabilization working solution and the 
embryos were incubated for 1 hr at room temperature in the dark. The anti-Nanog 
antibody was a mouse monoclonal antibody pre-labeled with Alexa Fluor® 488 
(eBioscience, San Diego, CA), the anti-Oct4 was a mouse monoclonal IgG2b, and the 
anti-Sox2 was a goat polyclonal IgG antibody (Santa Cruz Biotechnology, Dallas, TX). 
After primary antibody incubation the blastocysts were washed twice in permeabilization 
working solution for 5 min and incubated with 0.5 "l of the corresponding secondary 
antibody/fluorescent tag and 1 "l of 1,000 "g/ml Hoechst dye for 30 min at room 
temperature in the dark. Embryos that were stained with the pre-labeled anti-Nanog 
antibody did not necessitate secondary antibody incubation. Embryos were then mounted 
on a slide in 7 "l of Glycerin, covered with a cover slip with micro drops of petroleum 
jelly on the corners, and sealed under the cover slip using a border of Permount Mounting 
Media (Fischer Scientific, Waltham, MA). Slides were kept in the dark for at least 24 hr 
to dry before being placed on the microscope for image processing.    
 
Statistical Analysis 
!ChIP Q-PCR 
 A standard curve was produced using genomic DNA and Ct values were 
converted to ng of DNA. These values were then compared to the input sample, and 
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expressed as a percentage of DNA captured versus the input control that received no 
antibody. A two-way ANOVA was used to compare the source of DNA (IVF, SCNT, 
donor cell, or trophoblast cell), within each gene. Bonferonni’s post-hoc test was further 
used, and P-values less than 0.05 were considered significant.   
 
Real-Time PCR 
 
 !!Ct values were computed and used for gene expression analysis (Livak and 
Schmittgen, 2001). First, differing amounts of cDNA was accounted for by normalization 
to Ct values of the GAPDH housekeeping gene. This ! Ct is calculated for each cell type 
by subtracting the Ct value of the gene of interest from the GAPDH Ct value. Finally 
!!Ct values are calculated by subtracting the !Ct value of the gene of interest from the 
IVF !Ct value of the same gene of interest. Fold increase or decrease in expression levels 
was calculated by the formula 2-!!Ct, and those values were used in the Student’s t-test 
for pair-wise comparisons. Significance was considered P<0.05.  
 
Immunofluorescence 
 
 Embryos were imaged individually on a Zeiss Axio Observer microscope (Zeiss, 
Gottingen, Germany). A 20x objective was used, and digital images acquired using a 
high-resolution AxioCam mRM digital camera. Exposure time was set for each channel 
or fluorescent tag and kept consistent for each embryo type. Embryo images were then 
analyzed using Axiovision software. Briefly, a perimeter was manually drawn around 
each embryo and the total area was computed. Images from each channel (DAPI, GFP, 
and Cy3) were then analyzed for the total area within the embryo that had positive 
fluorescence in the corresponding channel. DAPI, or nuclear staining, provided the total 
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area of the nuclei in the embryo. GFP and Cy3 values were then calculated as a 
percentage of the area stained by DAPI. Because each protein in question is a nuclear 
protein, this calculation provides an adequate representation of the number or percentage 
of nuclei that contain the protein of interest. Groups of 20 blastocysts, 10 IVF and 10 
SCNT, were imaged for each protein of interest, and the percentages for each gene were 
averaged together. The student’s t-test again was used to test significance (P<0.05). 
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